Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Forkhead box P3 (FOXP3) is currently thought to be the most specific marker for naturally occurring CD4(+)CD25(+) T regulatory cells (nTregs). In mice, expression of FoxP3 is strictly correlated with regulatory activity, whereas increasing evidence suggests that in humans, activated T effector cells (Teffs) may also express FOXP3. In order to better define the role of FOXP3 in human Teff cells, we investigated the intensity and kinetics of expression in ex vivo Teff cells, suppressed Teff cells and Teff cell lines. We found that all dividing Teff cells expressed FOXP3, but only transiently, and at levels that were significantly lower than those in suppressive nTregs. This temporary expression in Teff cells was insufficient to suppress expression of reported targets of FOXP3 repressor activity, including CD127, IL-2 and IFN-gamma, and was not correlated with induction of a nTreg phenotype. Thus expression of FOXP3 is a normal consequence of CD4(+) T cell activation and, in humans, it can no longer be used as an exclusive marker of nTregs. These data indicate that our current understanding of how FOXP3 contributes to immune tolerance in humans needs to be re-evaluated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, even within Tregs the intensity of FOXP3 expression can change, with naive or resting populations of Tregs expressing lower levels of FOXP3 than activated Tregs [379, 380].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [380]
The cited source says what the claim attributes to it.
In the citing paper
“Since Tconvs can also upregulate CD25 and FOXP3, and downregulate CD127 [380, 386], it is critical to set gates for all of these markers on resting populations of T cells, typically using blood cells from healthy individuals.”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [380]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606 · cited 2×
“Recently, it was reported that human nTregs can be distinguished from Teff cells on the basis of low CD127 (IL-7Ra) expression ( 26 , 27), possibly due to the capacity of FOXP3 to interact with and repress the CD127 promoter (26).”
BackgroundRegulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279
Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060468 · Cited by 1,512 · cited 1×
“Recently, it was reported that human nTregs can be distinguished from Teff cells on the basis of low CD127 (IL-7Ra) expression (26, 27 ), possibly due to the capacity of FOXP3 to interact with and repress the CD127 promoter (26).”
BackgroundTNF/TNFR FAMILY MEMBERS IN COSTIMULATION OF T CELL RESPONSES
Watts, T. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115839 · Cited by 1,353
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells
R.Walker, M., Kasprowicz, D. J., Gersuk, V. H., Bènard, A., Van Landeghen, M., Buckner, J. H., & Ziegler, S. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19441 · Cited by 1,245
FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT
Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A. D., Stroud, J. C., Bates, D. L., Guo, L., Han, A., Ziegler, S. F., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.042 · Cited by 1,189
Cited by
Items 701–800 of 875
Kyvelidou, C., Chatzi, K. E., Semitekolou, M., Papathanassiou, X., Vassiliadis, S., & Athanassakis, I. (2009) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2009.02342.x · Cited by 4
T-Regulatory Cells in Lymph Nodes
Arce, J., Levin, M., Xie, Q., Albanese, J. M., & Ratech, H. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcpar39bfwnhwro · Cited by 4
Serana, F., Chiarini, M., Quirós-Roldán, E., Gotti, D., Zanotti, C., Sottini, A., Bertoli, D., Caimi, L., & Imberti, L. (2014) · The Open AIDS Journal · doi:10.2174/1874613601408010001 · Cited by 5
Camisaschi, C., Tazzari, M., Rivoltini, L., & Castelli, C. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0345-0_18 · Cited by 6
Gastric Adenocarcinoma in the Setting of IPEX Syndrome
Steffin, D., Bhar, S., Fishman, D. S., Rider, N. L., Naik-Mathuria, B. J., Martinez, C. A., & Venkatramani, R. (2021) · Case Reports in Immunology · doi:10.1155/2021/9967198 · Cited by 4
Frey, T., Kandolf-Zumpf, C., Kaempf, A., Schaffer, K., Hollenstein, M., Lampl, A., Kovarik, J. J., Strobl, J., Stary, G., Eckl‐Dorna, J., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02429-z · Cited by 4
“In contrast, and consistent with the well-characterized up-regulation of FOXP3 on activated Teff [27]FOXP3 as single marker did not reliably identify tTreg (both resting and activated) in mixed cultures with activated Teff (37.1 ± 4.1% and 26.8 ± 4.1% tTreg in the FOXP3 + fraction respectively).”
InfluentialBrezar, V., Ruffin, N., Lévy, Y., & Seddiki, N. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.06.003 · Cited by 3
Metzker, M., Shipkova, M., von Ahsen, N., Andag, R., Abe, M., Canzler, O., Klett, C., Leicht, S., Olbricht, C. J., & Wieland, E. (2016) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2016.05.019 · Cited by 3
Galectin-1 Cross-Linking of GM1 Ganglioside in Autoimmune Suppression
Ledeen, R. W., Wu, G., Bleich, D., Lu, Z.-H., & Gabius, H. (2012) · ACS symposium series · doi:10.1021/bk-2012-1115.ch006 · Cited by 4
Kim, D. W., Kim, Y., Kovari, B. P., Martinez, M., Miao, R., Yu, J. B., Mehta, R. J., Strosberg, J., Imanirad, I., & Kim, R. D. (2024) · Cancers · doi:10.3390/cancers16030556 · Cited by 4
“However, FOXP3-expressing T cells are heterogenous in colorectal cancer [19], and certain types of FOXP3-expressing T cells (FOXP3lo) and activation-induced FOXP3-expressing T cells have been reported as non-immunosuppressive T cells [19,22].”
BackgroundA novel approach to digital characterisation of Tertiary Lymphoid Structures in colorectal cancer
Munoz‐Erazo, L., Park, S. M., Lin, S., Chen, C. J., Zhou, L. Y. Y., Rhodes, J. L., Jeon, T., Fenton, S., McCall, J. L., Kemp, R. A., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1500792 · Cited by 3
Müller, B., Reinartz, S. M., van Egmond, D., Groot, E. J. J. D., Fokkens, W. J., & van Drunen, C. M. (2014) · Rhinology Journal · doi:10.4193/rhin13.223 · Cited by 4
“Although FoxP3 is expressed in regulatory CD4 T cells in man there is sufficient data to suggest that also effector T cells express FoxP3 (27-29).”
BackgroundAlbert, M. H., Yu, X., & Magg, T. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.07.027 · Cited by 3
“Recent reports have shown that in vitro activated human T cells undergo transient induction of Foxp3 which is not necessarily associated with conversion to regulatory T cells [35;36;37].”
BackgroundMontcuquet, N., Mercier‐Letondal, P., Perruche, S., Duperrier, A., Couturier, M., Bouchekioua, A., Bonyhadi, M. L., Ferrand, C., Tiberghien, P., & Robinet, É. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02843.x · Cited by 3
Current reviews of allergy and clinical immunology
Leung, D. Y. M., Ledford, D. K., Bacchetta, R., Gambineri, E., & Roncarolo, M. (2007) · Cited by 3
Self-citationThe Immunopathogenesis of HIV-1 Infection
Presti, R. M., & Pantaleo, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00092-7 · Cited by 3
Role of regulatory T-cells in chronic obstructive pulmonary disease
Eltrawy, H. H., Elshennawy, S. I., Abozaid, S. Y., & Mostafa, S. (2019) · The Scientific Journal of Al-Azhar Medical Faculty Girls · doi:10.4103/sjamf.sjamf_58_19 · Cited by 3
Buder, K., Zirngibl, M., Bapistella, S., Meerpohl, J. J., Strahm, B., Bassler, D., & Weitz, M. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009898.pub4 · Cited by 3
Chemokines, their receptors and features of development of the immune answer
Moskalev, A. V., Rudoy, A. S., & Apchel, V. Y. (2017) · Bulletin of the Russian Military Medical Academy · doi:10.17816/brmma623370 · Cited by 3
Umhoefer, J. M., Arce, M. M., Whalen, S., Dajani, R., Goudy, L., Kasinathan, S., Belk, J. A., Zhang, W., Zhou, R., Subramanya, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.30.610436 · Cited by 3
“Unlike its function in Tregs, transient expression of FOXP3 in Tconv does not prevent proliferation or expression of pro-inflammatory cytokines, including IL-2 and INF-γ 14,15 .”
InfluentialKunimitsu, M., Minematsu, T., Koudounas, S., Sanada, H., & Nakagami, G. (2024) · Annals of Plastic Surgery · doi:10.1097/sap.0000000000004092 · Cited by 3
Zarrinrad, G., Burkhardt, L.-M., Beltran-Mestres, C., Romero‐Suárez, S., Wagner, D. L., Schlickeiser, S., Stein, M., Wendering, D. J., de la Cebosa, I. J. C. D., Ehlen, L., et al. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201735 · Cited by 2
“19,45,46 The TSDR methylation levels were similar in Treg WT and FKBP12 KO -Treg and no significantly different demethylated positions were shown, while Tcon showed increased methylation, thus confirming Treg identity and stability according to published scientific guidelines.”
Gertow, J., Berglund, S., Okas, M., Kärre, K., Remberger, M., Mattsson, J., & Uhlin, M. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.01.018 · Cited by 2
Tesch, M. E., Zheng, Y. H., Guzmán‐Arocho, Y. D., Collins, L. C., Heng, Y. J., Tayob, N., Rosenberg, S. M., Ruddy, K. J., Tamimi, R. M., Schapira, L., et al. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-25-0948 · Cited by 6
IPEX Syndrome: Clinical Profile, Biological Features, and Current Treatment
Bacchetta, R., Passerini, L., & Roncarolo, M. G. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-478-4_8 · Cited by 2
Self-citationYamawaki, K., Inuo, C., Nomura, T., Tanaka, K., Nakajima, Y., Kondo, Y., Yoshikawa, T., Urisu, A., & Tsuge, I. (2015) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2015.09.020 · Cited by 2
Physiology and Pathology of Immune Dysregulation: Regulatory T Cells and Anergy
Tores, M. I., López‐Casado, M. Á., de León, C. P., Lorite, P., & Palomeque, T. (2017) · InTech eBooks · doi:10.5772/intechopen.71770 · Cited by 5
“According to a number of studies, not all FOXP3+ Tcells are functional Tregs, and it is possible to induce a portion of the Treg signature without the presence of FOXP3 [37, 38] since activated human T cells express Foxp3 transiently without acquiring suppressor capacity [39, 40] The essential aspect of the Treg cell…”
BackgroundLinfocitos T reguladores y respuesta inmune
Ulises Vergara, C. (2012) · Avances en Ciencias Veterinarias · doi:10.5354/0716-260x.2009.18279 · Cited by 2
Congenital Immune Dysregulation Disorders
Fleisher, T. A., Oliveira, J. B., & Torgerson, T. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-29875-9.00013-6 · Cited by 2
Tolerance in Organ Transplantation
Boucault, L., Bézie, S., Ossart, J., & Guillonneau, C. (2016) · InTech eBooks · doi:10.5772/62653 · Cited by 3
“[287] Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, et al.”
BackgroundWeitz, M., Strahm, B., Meerpohl, J. J., & Bassler, D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009898 · Cited by 2
Reduced phosphorylated Foxp3 levels in Crimean Congo haemorrhagic fever
Gazi, U. (2022) · Tropical biomedicine · doi:10.47665/tb.39.4.016 · Cited by 1
“…et al., 2007; Dunham et al., 2008), Foxp3 protein expression alone was suggested not to be enough for generation of Treg cells (Allan et al., 2005), and was also detected in blood cells without any regulatory function (Gavin et al., 2006; Allan et al., 2007; Wang et al., 2007; Miyara et al., 2009).”
BackgroundCardenas-Juarez, A., Uresti‐Rivera, E. E., Ochoa-González, F. D. L., Lira-Hernández, F. I., Lara-Ramirez, E. E., Morales, J. M. V., Rivas-Santiago, B. T., Portales‐Pérez, D. P., & García-Hernández, M. H. (2025) · Immunological Investigations · doi:10.1080/08820139.2025.2515411 · Cited by 1
“Activated human T cells can transiently express FOXP3 (Allan et al., 2007; Wang et al., 2007) and over expression of FOXP3 in T cells does not induce a suppressive FOXP3 + Treg cells phenotype (Allan et al., 2005; Tran et al., 2007).”
T Regulatory Mechanisms in Airway and Interstitial Lung Disease
Pastore, C., Stadler, B. D., Sperling, A. I., & Velez, T. E. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2703-4491 · Cited by 3
Regulatory T Cells and Nanomaterials: Dual Perspectives in Therapeutics and Immunomodulation
Chen, Y. H., Huang, H., Wang, X., Yu, X., Huang, Z., Jin, Z., Chen, C., Chen, Y., Blazar, B. R., Xu, Y., et al. (2025) · Small Science · doi:10.1002/smsc.202500481 · Cited by 2
A stage-based framework to interpret regulatory T cell biology after heart transplantation
Wang, Y., Ni, M., Zheng, A., Peng, Y., Liu, J., Xiong, Q., Wang, X., Savković, V., & Kang, S. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1777360 · Cited by 2
“However, metrics of Treg detection do not necessarily equate to their stability or suppressive function (6).”
Georgieva, Z. G., Howlett, S., Rainbow, D. B., Coppard, V., Ellis, L., Jarvis, L. B., Williams, E., Yang, J. H. M., Sun, B., Tree, T. I. M., et al. (2026) · Brain · doi:10.1093/brain/awag171 · Cited by 2
Chen, Y., Shi, Y., & You, J. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02910-2 · Cited by 2
“56 However, a small amount of transient Foxp3 expression can also be present in CD4 + Tconv cells, 57 – 59 and high levels of Foxp3 expression can be induced in the presence of TGF-β , 60 especially among humans.”
Vitamin D and Regulatory T Cells
Urry, Z., Dimeloe, S., & Hawrylowicz, C. M. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-888-7_5 · Cited by 1
Immunological Tolerance—T Cells
Hamilton, S. R., Crome, S. Q., & Ohashi, P. S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00007-1 · Cited by 1
Self-citationŠvec, P., Vásárhelyi, B., CIZMAR, A., Tulassay, T., & Treszl, A. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02492.x · Cited by 1
CD25+, CD30+Adult T-Cell Leukemia/Lymphoma cells, Virus-Infected Cells or Regulatory T-Cells?
Takemoto, S. (2014) · Journal of Hematology & Thromboembolic Diseases · doi:10.4172/2329-8790.1000175 · Cited by 1
“Although the expression of FoxP3 is a normal consequence of CD4+ T cell activation, CD30 expression can discriminate activation-induced FoxP3+CD4+CD25+ Tregs [14,15].”
BackgroundThe Role of T-regulatory Cells in Immune Senescence
Moss, P. A. H. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9063-9_10 · Cited by 1
“A complexity is that FoxP3 may be expressed transiently after T-cell activation of effector T-cells although this induction does not lead to acquisition of complete regulatory function [ 27 ].”
BackgroundMiyara, M., & Sakaguchi, S. (2008) · Springer eBooks · doi:10.1007/978-0-387-77909-6_1 · Cited by 1
“conclusions might be someday obsolete since FoxP3 has recently been shown to be also upregulated in activated CD4+ T cells, exactly like CD25 or GITR [83, 84].”
BackgroundMjösberg, J., Svensson, J., Johansson, E. O., Hellström, L., Casas, R., Jenmalm, M. C., Boij, R., Matthiesen, L., Jönsson, J.-I., Berg, G., et al. (2009) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2009.06.225 · Cited by 1
Nakajima, A., Murakami, R., & Hori, S. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2647-4_7 · Cited by 1
Analysis of FOXP3 DNA Methylation Patterns to Identify Functional FOXP3+ T-Cell Subpopulations
Minskaia, E., & de Lacerda, J. F. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2647-4_9 · Cited by 1
Hamid, O., Cardin, D. B., Hodi, F. S., LoRusso, P. M., Merghoub, T., Zappasodi, R., Maniyar, R. R., Janik, J. E., van der Velden, M. V. W., Zhou, F., et al. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-4141 · Cited by 1
“TCR-mediated signaling leads to GITR upregulation in both CD4 + and CD8 + T cells (12, 13, 19, 20).”
Chikileva, I. O., Shubina, I. Z., & Kiselevskii, E. V. (2012) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn.v67i4.201 · Cited by 1
Foxp3+ and CD4CD25+ T cells and its Clinical Relation to Type 1 Diabetes
Albrra, A. Y., Salman, W., & Omran, M. A. (2015) · Journals & Books Hosting (International Knowledge Sharing Platform) · Cited by 1
Hematopoietic Stem Cell Transplant and Cellular Therapy
Tewari, P., Bajwa, R. P. S., Taraseviciute, A., Moffet, J., McCall, D. C., & Mahadeo, K. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-01322-6_8 · Cited by 1
Vergani, D., Mackay, I. R., & Mieli‐Vergani, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00057-9 · Cited by 2
Prospects for studying of FOXP3 and its isoforms expression in allergic diseases
Smirnov, D. S., Kurbacheva, O. M., Polner, S. A., & Pavlova, K. S. (2017) · Russian Journal of Allergy · doi:10.36691/rja320 · Cited by 1
Study of immunomics and immune regulation in ovarian cancer
Aziz, A. (2013) · Spiral (Imperial College London) · doi:10.25560/23897 · Cited by 1
Immunological profile and aspects of immunotherapy in type 1 diabetes
Hjorth, M. (2010) · DiVA (Linkoping University) · Cited by 1
On the regulation of immune responses to dietary and self antigens
Lindgrén, S. (2010) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
FoxP3 mRNA splice forms in arthritis patients
Ryder, L. R. (2011) · Cited by 1
Design and delivery strategies of alphavirus replicon-based cervical cancer vaccines
van de Wall, M.-N. S. (2018) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 1
Milne, K., Köbel, M., Kalloger, S. E., Barnes, R. O., Gao, D., Gilks, C. B., Watson, P. H., & Nelson, B. H. (2013) · PLoS ONE · doi:10.1371/annotation/976c923b-d991-4a33-b060-cdd8770bdf5d · Cited by 1
“Although FoxP3 is still regarded as the most reliable marker of Tregs in human cancer [82,83], it can also be expressed by epithelial tumor cells [84-86] and in vitro activated CD4+ and CD8+ T cells [87-95].”
BackgroundThe molecular regulation of Forkhead box P3
Jochems, S. P. (2011) · Utrecht University Repository (Utrecht University)
Potential role of IL-10-treated dendritic cells in the control of the immune response to allergens
Pacciani, V. (2008) · Cineca Institutional Research Information System (Tor Vergata University) · doi:10.58015/pacciani-valentina_phd2008-08-28
PATOFIZIOLOŠKI MEHANIZMI U NASTANKU I LIJEČENJU ALERGIJSKIH BOLESTI
Pevec, B., Pevec, M. R., Marković, A. S., & Batišta, I. (2011) · Acta medica Croatica · Cited by 1
Regulation of immunity in Multiple Sclerosis : CD4+ T cells and the influence of natalizumab
Edström, M. (2014) · Linköping University medical dissertations · doi:10.3384/diss.diva-108910
Análise do envolvimento de células T reguladoras na hanseníase
Lima, H. R. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.25.2012.tde-03042013-104808 · Cited by 1
Immunosuppressive Drugs and Immune Regulation in Organ Transplantation
Sewgobind, V. D. K. D. (2010) · EUR Research Repository (Erasmus University Rotterdam)
Amorocho, D., & Alberto, O. (2010)
Mundin, G. S. P. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2008.tde-28012009-131608
Effects of pro-inflammatory cytokines on iTReg differentiation and function
Halldórsdóttir, S. (2013)
T Regulatory Cells – Friends or Foes?
Lindqvist, C. A. (2010) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 2
Funktion natürlicher Isoformen des Transkriptionsfaktors FOXP3 in regulatorischen CD4+ T-Zellen
Mailer, R. K. (2009) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-13397
Development of regulatory T cells in the human thymus
Tuovinen, H. (2009) · Työväentutkimus Vuosikirja
Rintamäki, H. (2012) · Helda - University of Helsinki Institutional Repository
Yang, D. S. (2012) · UCL Discovery (University College London) · Cited by 1
Immunosuppression-Free Renal Transplantation
Fändrich, F. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398523-1.00062-8
Lopes, R. M. G. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2014.tde-15122014-162230 · Cited by 1
Molecular Signalling in T Regulatory Cells
Locke, N. R., Crellin, N. K., & Levings, M. K. (2008) · Springer eBooks · doi:10.1007/978-0-387-77909-6_8
Self-citationIslet antigen-specific T cells and regulatory T cells in type 1 diabetes
Öling, V. (2010) · UTUPub (University of Turku) · Cited by 1
Innate and Adaptive Immune Responses in Pulmonary Sarcoidosis
Wikén, M. (2010) · Figshare
Untersuchungen zu regulatorischen T-Zellen (Treg) beim Multiplen Myelom
Hülsmann, B. (2010) · DuEPublico (University of Duisburg-Essen)
Regulatory T cells in human pregnancy
Mjösberg, J. (2010) · DiVA (Linkoping University) · Cited by 2
Molecular Genetics of the IPEX Syndrome
Dhuban, K. B., & Piccirillo, C. A. (2015) · Wiley eBooks · doi:10.1002/9780470015902.a0024904
Regulatory T-like cells: Another variation on the theme of hypomorphic mutations?
Notarangelo, L. D. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.09.001
In vitro generation of human FOXP3+ regulatory T cells
Abdulrasool, G. A. E. S. (2014) · The Sydney eScholarship Repository (The University of Sydney)
Hirata, B. K. B., Oda, J. M. M., Borelli, S. D., & Watanabe, M. A. E. (2013) · Semina Ciências Biológicas e da Saúde · doi:10.5433/1679-0367.2012v33n2p223
Influencia de la catepsina L en la población de células T regulatorias CD4+: rol del estroma
Camicia, G. (2011) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Александрович, С. К. (2013) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2013.42029
“[20] shows that effector T-lymphocytes, after stimulation lipohexopeptide and flagellin-ligands, respectively, for TLR-2 and TLR-5, produce IL-2.”
BackgroundIncreased expression of regulatory T cell-associated markers in recent-onset diabetic children
Pihl, M., Chéramy, M., Mjösberg, J., Ludvigsson, J., & Casas, R. (2011) · Open Journal of Immunology · doi:10.4236/oji.2011.13007
“PCH101 has been shown to bind both isoforms of FOXP3 [8].”
BackgroundPediatric immune thrombocytopenia: Catching platelets
Laarhoven, A. G. (2015) · UvA-DARE (University of Amsterdam)
THE ROLE OF REGULATORY T CELLS IN ADULTS IN SOUTH AFRICA WITH ACTIVE TUBERCULOSIS
Mayne, E. S. (2010) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
Bendfeldt, H. (2010) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-16736 · Cited by 1
Grindebacke, H. (2010)
Adoptive Immunotherapy of Malignant Effusions
Shubina, I. Z., Титов, К. С., Chikileva, I. O., Демидов, Л. В., & Kiselevsky, M. V. (2012) · Springer eBooks · doi:10.1007/978-94-007-4783-8_6
Santegoets, S. J. A. M., Turksma, A. W., Suhoski, M. M., Stam, A. G. M., Albelda, S. M., Hooijberg, E., Scheper, R. J., Gerritsen, W. R., Powell, D. J., June, C. H., et al. (2013)
Sun, W., Li, W., Wu, C. Y., Zhong, H., & Wen, W. (2014)
Review Article Regulatory T cells and regulation of allergic airway disease
Martin, H., & Taube, C. (2012)
Foxp3+ Regulatory T Cells: a Protagonist in the "Movie'' of Autoimmune
Liu, Y., Ryffel, B., & Zheng, S. G. (2011)
Fanelli, G. (2013) · IRIS Research product catalog (Sapienza University of Rome)
Metadata
- Authors
- Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G., & Levings, M. K.
- Affiliations
- University of British Columbia (CA)
- The San Raffaele Telethon Institute for Gene Therapy (IT)
- Vita-Salute San Raffaele University (IT)
- Venue
- International Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-02-20
- Volume
- 19
- Issue
- 4
- Pages
- 345-354
- ISSN
- 0953-8178 (ISSN-L)
- 1460-2377
- OpenAlex
- W2139019810
- Cited by
- 872
- References
- 39
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 24 · 2023: 21 · 2022: 25 · 2021: 33 · 2020: 22 · 2019: 34 · 2018: 34 · 2017: 36 · 2016: 26 · 2015: 46 · 2014: 62 · 2013: 62 · 2012: 67
- FWCI
- 34.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Immunology (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Foxp3, CD4+CD25+ T cells, T cell activation, T cell proliferation, cytokine production, CD127, interleukin-2, interferon-gamma, immune tolerance, human T cells
- MeSH terms
- CD69 Antigens, Antibodies, Antigens, Differentiation, Antigens, Differentiation, T-Lymphocyte, Cell Line, Cysteine, Flagellin, Humans, Interferon-gamma, Interleukin-2, Lipoproteins, Lymphocyte Activation, CD4-Positive T-Lymphocytes, Antigens, CD, T-Lymphocyte Subsets, Cytokines, CD3 Complex, Receptors, Nerve Growth Factor, Clonal Anergy, CD28 Antigens, Receptors, Tumor Necrosis Factor, Coculture Techniques, Lectins, C-Type, Cell Proliferation, T-Lymphocytes, Regulatory, Toll-Like Receptors, Forkhead Transcription Factors, Glucocorticoid-Induced TNFR-Related Protein, Interleukin-2 Receptor alpha Subunit, Interleukin-7 Receptor alpha Subunit, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.